5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

614 views

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur group transfer to the substrate, and sulfated metabolite creation. Various drugs, including those containing phenols, alcohols, arylamines, N-hydroxylamines, and N-hydroxyamides (such as acetaminophen, minoxidil, and morphine), undergo sulfation. The resulting sulfoconjugates are pharmacologically active and may cause tissue damage or carcinogenesis.

α-amino acid conjugation, another phase II reaction, involves linking a drug to an α-amino acid like glycine or glutamine. This reaction is catalyzed by acyltransferases. The reaction mechanism involves activating the α-amino acid, its transfer to the drug substrate, and the formation of the conjugated metabolite. Drugs with aliphatic, alicyclic, aryl, or heterocyclic aryl acids, such as salicylic and valproic acids, undergo α-amino acid conjugation.

Tags

Phase II ReactionsSulfationConjugationBiotransformationDrug MetabolismSulfate GroupWater SolubilityGlucuronidationSulfotransferase EnzymesPAPS CoenzymeSulfated MetabolitePharmacologically ActiveTissue DamageCarcinogenesisAcyltransferasesAmino Acid Conjugation

From Chapter 5:

Now Playing

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

614 Views

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

2.0K Views

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

477 Views

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

441 Views

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

236 Views

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

356 Views

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

357 Views

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

498 Views

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

1.2K Views

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

524 Views

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

488 Views

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

472 Views

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

191 Views

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

546 Views

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

356 Views